"Promoting and supporting research into diabetes
and metabolic diseases".

For the advancement of diabetes research

A la Une

DISCOVER THE 2024 WINNERS!

 

The scientific council of the FFRD has made its decision! 2024 marks its 12th call for projects with nearly 40 Francophones applicants

 

Since 2013, a total of :

  • 371 projects received
  • 153 experts solicited
  • 81 candidates interviewed
  • 31 Francophones recipients
  • 8,3 million Euros distributed!

 

 

The FFRD thanks its faithful partners and donors and is proud to dédicate more than 80% of its expenditures to diabetes research in Francophonie!

Next FFRD call for projects (with new features!) in February 2025…

 

 

DISCOVER THE 2024 WINNERS!

News

The upcoming events of the FFRD

14
Nov
World Diabetes Day
10
Dec
Board Meeting

Finalization of the agenda for the Board of Directors
Overview of 2024 and projections for 2025
Validation of the 2025 agenda

President’s foreword

Diabetes mellitus affects 5% of the French population and is a major burden for the persons living with this chronic disease, with potentially serious complications and high costs induced. Major and continuous improvements have been made for a botter understanding of the mechanisms of the disease and its complications, and for its monitoring and treatment as well.

The FFRD supports all research on diabetes.

The FFRD supports clinical, basic, and translational research.

The supported basic research projects address major themes of type 1 and type 2 diabetes

covering subjects such as pancreatic beta cells, insulin resistance, and intestinal microbiota.

The clinical research projects, on the other hand, address the themes of type 1 and type 2 diabetes, as well as gestational diabetes

and often involve large multicenter cohort studies.

Since 2013, the Foundation has been:

0
years of existence
0
teams of supported researchers
0
euros in annual grants
0
million of euros distributed
0
% of expenses allocated to research

The recipients of the year

Soraya TALEB
Soraya TALEB
PARCC, INSERM, Hôpital G. Pompidou, Paris
Basic Research Project
200 000
Olivier BOURRON
Olivier BOURRON
INSERM, Hôpital Pitié-Salpêtrière, Paris
Clinical Research Project
200 000
Mikaël CROYAL
Mikaël CROYAL
INSERM, Institut du Thorax, Nantes
Translational Research Project
200 000

They support us